Literature DB >> 25433836

Bullous fixed drug eruption masquerading as recurrent Stevens Johnson syndrome.

Farid M Dharamsi1, Michael D Michener2, Jennifer Warner Dharamsi3.   

Abstract

BACKGROUND: Fixed drug eruptions (FDE) are peculiar drug rashes that tend to be violaceous, hyperpigmented, and round to oval-shaped plaques with dusky gray centers. The lesions tend to recur in a similar dermatologic distribution upon re-exposure to the offending medication, leading to intensified inflammation and sometimes the formation of blisters, bullae, and erosions. This bullous form of FDE can be mistaken clinically for Stevens Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN). CASE REPORT: We report two cases of patients presenting to the emergency department (ED) with characteristic blistering skin lesions and reports of similar prior episodes; both patients were initially diagnosed in the ED as "recurrent SJS" and admitted to the burn intensive care unit. Each patient was evaluated emergently by dermatology consultants, identified as cases of FDE rather than SJS, and transferred to the general medical ward with an uncomplicated hospital course and complete re-epithelialization within 7 days after removal of the inciting agent. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: We discuss distinguishing features of bullous FDE and SJS/TEN in order to highlight this entity and aid in diagnostic accuracy and appropriate management by emergency physicians. In cases identified as classic or suspected SJS/TEN, the patient warrants aggressive resuscitation and admission to a burn unit, while cases identified as obvious bullous FDE can be managed much more conservatively. Although the clinical clues outlined here may help distinguish classic cases of FDE from SJS/TEN, it is always advisable to admit to a higher level of care or obtain an urgent dermatology consult when diagnostic uncertainty remains. Published by Elsevier Inc.

Entities:  

Keywords:  Stevens Johnson syndrome; drug eruption; drug rash; fixed drug eruption; toxic epidermal necrolysis

Mesh:

Substances:

Year:  2014        PMID: 25433836     DOI: 10.1016/j.jemermed.2014.09.049

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  3 in total

1.  Fixed Drug Eruption: An Underrecognized Cutaneous Manifestation of a Drug Reaction in the Primary Care Setting.

Authors:  George Shaker; Teja Mehendale; Charles De La Rosa
Journal:  Cureus       Date:  2022-08-23

Review 2.  Bullous Drug Reactions.

Authors:  Maja Mockenhaupt
Journal:  Acta Derm Venereol       Date:  2020-02-12       Impact factor: 3.875

3.  Bullous Fixed Drug Eruption Following Ibuprofen Ingestion.

Authors:  Seyed Amirhossein Fazeli; Morteza Abbasi; Hadi Jalali; Sonia Eskandari; Farzaneh Shamshirgaran; Zahra Dehghani; Reza Golabchifard; Shahram Ghiyasvand; Kaveh Ghannad
Journal:  J Res Pharm Pract       Date:  2018 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.